Vaccines save millions of lives every year, but there is still an urgent need for more efficient vaccines. Strategies to combat serious outbreaks of viral infections are particularly important. Such ...

F protein-subunit based vaccines, adjuvants & potency Both prefusion and postfusion F protein vaccines are being tested in clinical trials. Previous studies showed that alum had a modest effect on ...

Vaccines save millions of lives every year, but there is still an urgent need for more efficient vaccines that target pathogens transmitted through the respiratory tract and may cause fatal infections ...

Virus-like particles (VLPs) are being investigated as a novel alternative to the traditional vaccines currently available. VLPs are made entirely of proteins and thus would make non-infectious and ...

Empathetic and persistent communication is key when it comes to talking to parents who are reluctant to vaccinate their child ...

The government is putting money into a new kind of vaccine that could work against different types of viruses with just one ...

There are currently three vaccines approved for RSV; two of them -- GSK's Arexvy and Pfizer's Abrysvo -- are protein subunit vaccines, while Moderna's mResvia is a messenger RNA vaccine.